The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry

BACKGROUND: Immune checkpoint inhibitors (ICIs) are quickly becoming key instruments in the treatment of mismatch repair-deficient (dMMR) colorectal cancers (CRCs). Despite their clinical value, ICIs have several limitations associated with their use. Only approximately 15% of all CRCs have a dMMR s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Hongkai, Li, Yaqi, Wang, Xiaoyu, Qian, Juanjuan, Xu, Midie, Peng, Junjie, Huang, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163547/
https://www.ncbi.nlm.nih.gov/pubmed/35669431
http://dx.doi.org/10.3389/fonc.2022.867658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163547/
https://www.ncbi.nlm.nih.gov/pubmed/35669431
http://dx.doi.org/10.3389/fonc.2022.867658

Ejemplares similares